PMID- 21167926 OWN - NLM STAT- MEDLINE DCOM- 20111107 LR - 20220311 IS - 1872-7573 (Electronic) IS - 0378-8741 (Linking) VI - 134 IP - 2 DP - 2011 Mar 24 TI - Panax notoginseng saponins promotes proliferation and osteogenic differentiation of rat bone marrow stromal cells. PG - 268-74 LID - 10.1016/j.jep.2010.11.075 [doi] AB - AIM OF THE STUDY: Panax notoginseng saponins (PNS) is the main effective component of Panax notoginseng, have various pharmacologic activities such as antioxidant, anti-inflammatory, and estrogen-like bioactivities, have been shown to be an effective agent on anti-osteoporosis. Bone marrow stromal cells (BMSCs) play a crucial homeostatic role in skeletal modeling and remodeling due to their capability to differentiate into osteooblasts. Whether PNS has effect on osteogenic differentiation of BMSCs are unknown. This study was designed to investigate the effects of PNS on the proliferation and osteogenic differentiation of BMSCs in vitro. MATERIALS AND METHODS: When BMSCs cultivated in the basal medium or the osteogenic induction medium (OS with or without PNS), cell proliferation was analyzed using an MTT assay, the mineralization was assessed using Alizarin red S staining, the alkaline phosphatase activity was measured using a commercial kit, the mRNA level of osteogenic gene and PPARgamma2 gene were determined using RT-PCR, the protein level of PPARgamma2 was analyzed by Western blotting. RESULTS: BMSCs cultured in the basal medium with PNS caused a significant increase in proliferation. PNS treatment increased ALP activity, Alizarin red S staining and mRNA level of ALP, Cbfa 1, OC, and BSP, whereas decreased the mRNA level and protein expression of PPARgamma2 during osteogenic induction. In addition, the effects of PNS treatment were dose-dependent relationship. CONCLUSION: PNS could stimulate BMSCs proliferation and promote their osteogenic differentiation by up-regulation expression of osteogenic marker gene and down-regulation expression of adipogenic marker gene in a dose-dependent manner. Thus, PNS may play an important therapeutic role in osteoporosis patients by improving osteogenic differentiation of BMSCs. CI - Crown Copyright (c) 2010. Published by Elsevier Ireland Ltd. All rights reserved. FAU - Li, Xue-Dong AU - Li XD AD - Department of Orthopaedics, The First Affiliated Hospital, Shantou University Medical College, 57 Chang Ping Road, Shantou, Guangdong 515041, China. FAU - Wang, Jian-Sheng AU - Wang JS FAU - Chang, Bo AU - Chang B FAU - Chen, Bin AU - Chen B FAU - Guo, Chun AU - Guo C FAU - Hou, Guo-Qing AU - Hou GQ FAU - Huang, Dong-Yang AU - Huang DY FAU - Du, Shi-Xin AU - Du SX LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20101216 PL - Ireland TA - J Ethnopharmacol JT - Journal of ethnopharmacology JID - 7903310 RN - 0 (Bone Density Conservation Agents) RN - 0 (Core Binding Factor alpha Subunits) RN - 0 (Integrin-Binding Sialoprotein) RN - 0 (PPAR gamma) RN - 0 (Plant Extracts) RN - 0 (RNA, Messenger) RN - 0 (Saponins) RN - 0 (core binding factor alpha) RN - 104982-03-8 (Osteocalcin) RN - EC 3.1.3.1 (Alkaline Phosphatase) SB - IM MH - Alkaline Phosphatase/genetics/metabolism MH - Animals MH - Bone Density Conservation Agents/pharmacology/therapeutic use MH - Bone Marrow Cells/*drug effects/metabolism MH - Cell Differentiation/drug effects MH - Cell Proliferation/drug effects MH - Core Binding Factor alpha Subunits/genetics/metabolism MH - Dose-Response Relationship, Drug MH - Integrin-Binding Sialoprotein/genetics/metabolism MH - Mesenchymal Stem Cells/*drug effects/metabolism MH - Osteocalcin/genetics/metabolism MH - Osteogenesis/*drug effects MH - Osteoporosis/*drug therapy/metabolism MH - PPAR gamma/genetics/metabolism MH - Panax notoginseng/*chemistry MH - Phytotherapy MH - Plant Extracts/*pharmacology/therapeutic use MH - RNA, Messenger/metabolism MH - Rats MH - Saponins/*pharmacology/therapeutic use MH - Stromal Cells/drug effects/metabolism EDAT- 2010/12/21 06:00 MHDA- 2011/11/08 06:00 CRDT- 2010/12/21 06:00 PHST- 2010/06/10 00:00 [received] PHST- 2010/11/04 00:00 [revised] PHST- 2010/11/21 00:00 [accepted] PHST- 2010/12/21 06:00 [entrez] PHST- 2010/12/21 06:00 [pubmed] PHST- 2011/11/08 06:00 [medline] AID - S0378-8741(10)00873-1 [pii] AID - 10.1016/j.jep.2010.11.075 [doi] PST - ppublish SO - J Ethnopharmacol. 2011 Mar 24;134(2):268-74. doi: 10.1016/j.jep.2010.11.075. Epub 2010 Dec 16.